智云健康在港交所上市，保持初心，始終以患者為中心，致力于讓數(shù)字健康走進千家萬戶 ClouDr Group's listing on the Hong Kong Stock Exchange marks a significant milestone in our journey. We remain true to our original aspiration, steadfastly focusing on patients and committed to bringing digital health into every household.
雙SaaS系統(tǒng)、智云健康A(chǔ)PP、智云醫(yī)生APP等產(chǎn)品矩陣，形成“醫(yī)患藥付”一站式慢病管理生態(tài)，實現(xiàn)自我造血獲得市場認(rèn)可 The dual SaaS system, ClouDr Mini Program, Dr ClouDr and other product matrices have formed a one-stop chronic disease management ecosystem of "doctors, patients, drug, payment". ClouDr has achieved self-growth and gained market recognition.
合作醫(yī)院近1000家，業(yè)務(wù)收入實現(xiàn)300%的增長 Close to 1,000 partner hospitals; 300% growth in revenues Team expanded with many talents from leaders in the medical and internet industries, such as Johnson & Johnson, Kanghong Pharmaceutical, and Alibaba, among others
吸引大批來自強生、康弘藥業(yè)、阿里巴巴等醫(yī)療與互聯(lián)網(wǎng)頭部公司優(yōu)秀人才加入
Hangzhou Kangsheng Health Management and Consulting Co., Ltd. founded.
Our mission: Leverage internet technologies to build stronger trust between doctors and patients, make healthcare more efficient and to improve the allocation of medical resources
智云快藥，智云藥城助力中小藥店逆勢增長；互聯(lián)網(wǎng)醫(yī)療服務(wù)拓展線上場景，成為國內(nèi)最大線上醫(yī)療服務(wù)器；升級智云醫(yī)療大腦，推出兩個醫(yī)療行業(yè)模型-ClouDGPT、ClouD DTx ClouDr Express, the B2B one-stop procurement, and ClouDr Drug City O2O help small and medium-sized pharmacies to grow. The Internet medical service has been expanded to online scenarios such as Meituan, Ali, etc., and the average daily number of consultation services has exceeded 900,000 times, becoming the largest online medical service provider in China. We upgraded our medical brain and launched two medical industry models - ClouD GPT and CIouD DTx.
布局高端智造寶利化制藥品牌重塑，打造科技創(chuàng)新驅(qū)動與數(shù)字研發(fā)的現(xiàn)代化制藥集團，加強數(shù)字化和智能化技術(shù)競爭力 Lay out the brand of Polifarma Pharmaceutical in the high-end intelligent manufacturing sector, create a modern pharmaceutical group driven by scientific and technological innovation and digital research and development, and strengthen the competitiveness of digital and intelligent technologies.
建立了院內(nèi)院外、線上線下聯(lián)合的數(shù)字化慢病全生命周期管理的創(chuàng)新生態(tài)體系，提出“健康中國2030計劃”，部署線下健康小站 It has established an innovative ecosystem for the full-life cycle management of chronic diseases, integrating both in-hospital and out-of-hospital, as well as online and offline approaches. It has put forward the "Healthy China 2030 Plan" and deployed health stations.
開拓院外場景，上線藥店SaaS系統(tǒng)——智云問診，年底前已覆蓋3005家，持續(xù)拓展慢病生態(tài)鏈，全面提升技術(shù)與服務(wù)品質(zhì) Exploring out-of-hospital market and launch the pharmacy SaaS system, "ClouDr Consultation". By the end of the year, we have covered 3,005 pharmacies. We will expand the ecosystem of chronic disease management, aiming to comprehensively enhance technology and service quality.
業(yè)務(wù)戰(zhàn)略全面升級，服務(wù)范圍由糖尿病延展至整個慢病領(lǐng)域，同時品牌名稱升級為“智云健康”，成為中國最大的數(shù)字化慢病管理解決方案提供商 The business strategy has been upgraded. The service scope has been extended from diabetes to the entire chronic disease field. Meanwhile, the brand name has been upgraded to ClouDr Group, which is the largest provider of digital chronic disease management solutions in China.
